These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6407306)

  • 1. Association of IgE antibodies to sodium aurothiomalate and adverse reactions to chrysotherapy for rheumatoid arthritis.
    Bretza J; Wells I; Novey HS
    Am J Med; 1983 Jun; 74(6):945-50. PubMed ID: 6407306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis.
    Dorwart BB; Gall EP; Schumacher HR; Krauser RE
    Arthritis Rheum; 1978 Jun; 21(5):513-5. PubMed ID: 96841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic reactions to chrysotherapy treated with iv N-acetylcysteine.
    Taylor PW; Fischbein L
    J Rheumatol; 1984 Aug; 11(4):562-3. PubMed ID: 6434740
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin rashes and stomatitis due to parenteral treatment of rheumatoid arthritis with sodium aurothiomalate.
    Svensson A; Theander J
    Ann Rheum Dis; 1992 Mar; 51(3):326-9. PubMed ID: 1533505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance chrysotherapy in rheumatoid arthritis: a comparison of 2 dose schedules.
    Griffin AJ; Gibson T; Huston G; Taylor A
    Ann Rheum Dis; 1981 Jun; 40(3):250-3. PubMed ID: 6787995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal chrysiasis and clinical improvement with chrysotherapy in rheumatoid arthritis.
    Prouse PJ; Kanski JJ; Gumpel JM
    Ann Rheum Dis; 1981 Dec; 40(6):564-6. PubMed ID: 6800311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis.
    Taukumova LA; Mouravjoy YuV ; Gribakin SG
    Adv Exp Med Biol; 1999; 455():367-73. PubMed ID: 10599371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
    Wiland P; Głowska A; Chlebicki A; Szechiński J
    Pol Arch Med Wewn; 2002 Nov; 108(5):1055-63. PubMed ID: 12685246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IV N-acetylcysteine treatment of hematologic reactions to chrysotherapy.
    Godfrey NF; Peter A; Simon TM; Lorber A
    J Rheumatol; 1982; 9(4):519-26. PubMed ID: 6813467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse immune reactions to gold in rheumatoid arthritis: lack of skin reactivity.
    Goldermann R; Schuppe HC; Gleichmann E; Kind P; Merk H; Rau R; Goerz G
    Acta Derm Venereol; 1993 Jun; 73(3):220-2. PubMed ID: 8105626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis].
    Rodríguez Pérez M; González Domínguez J; Matarán Pérez L; Salvatierra Ríos D
    An Med Interna; 1993 Oct; 10(10):484-6. PubMed ID: 8136425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold therapy in rheumatoid arthritis.
    Majoos FL; Klemp P; Meyers OL; Briggs B
    S Afr Med J; 1981 Jun; 59(27):971-4. PubMed ID: 6787722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postinjection nonvasomotor reactions during chrysotherapy. Constitutional and rheumatic symptoms following injections of gold salts.
    Halla JT; Hardin JG; Linn JE
    Arthritis Rheum; 1977; 20(6):1188-91. PubMed ID: 409414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term chrysotherapy in rheumatoid arthritis.
    Srinivasan R; Miller BL; Paulus HE
    Arthritis Rheum; 1979 Feb; 22(2):105-10. PubMed ID: 105739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is gold necessary in so called chrysotherapy?
    Munthe E; Jellum E
    Scand J Rheumatol Suppl; 1983; 51():46-51. PubMed ID: 6426053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term chrysotherapy: incidence of toxicity and efficacy during sequential time periods.
    Kean WF; Anastassiades TP
    Arthritis Rheum; 1979 May; 22(5):495-501. PubMed ID: 156026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.
    Danpure CJ; Fyfe DA; Gumpel JM
    Ann Rheum Dis; 1979 Aug; 38(4):364-70. PubMed ID: 115389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired delayed type cutaneous hypersensitivity in rheumatoid arthritis reversed by chrysotherapy.
    Smith MD; Smith A; O'Donnell J; Ahern MJ; Roberts-Thomson PJ
    Ann Rheum Dis; 1989 Feb; 48(2):108-13. PubMed ID: 2494956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.